Cerecor is a clinical-stage biopharmaceutical company developing innovative drug candidates to make a difference in the lives of patients with neurological and psychiatric disorders. Cerecor's lead drug candidate is CERC-301, which Cerecor currently intends to explore as a novel treatment for orphan neurological indications.
400 East Pratt Street
Baltimore, MD 21202
Pharmaceutical Preparation Manufacturing (325412)
Pharmaceutical Preparations (2834)